The shares of South Korean e-commerce giant Coupang are down 46% since its $4.6B US IPO one year ago
Filipe Pacheco / Bloomberg :
Context & Ripple Effects
Coupang came to market at the top of the pandemic e-commerce boom: it filed for its US IPO reporting 2020 revenue of $12B against $6.3B in 2019 after revenue nearly doubled in a year, then priced at $35 — above its raised target range — for a market value of roughly $60B after pricing above its target range. Even the debut hinted at stretched expectations: the stock opened at $63.50 and closed its first session at $49.25 below where it opened on day one.
One year on, the stock is down 46%, and the arc since has been a grind of decelerating growth and mounting liabilities: a Q4 2023 report that missed estimates on both revenue (+4.9%) and active customers (+1%), then a 2025 breach exposing ~33.7M accounts that brought a $1B-plus compensation offer, a $409M fine, and Coupang's largest quarterly net loss since Q4 2021.
First-order effects
- Every shareholder cohort is underwater — allocation holders at the $35 IPO price and first-day buyers at $49.25 alike — unwinding the premium Coupang captured by pricing above its target range.
- The drawdown puts the ~$60B IPO valuation out of reach and strips the company of the equity currency a hypergrowth listing was supposed to provide.
Second-order effects
- Without a valuation cushion, Coupang's loss-making quarters land harder: the $556M Q2 operating loss and the ~$266M Q1 2026 net loss — its largest since Q4 2021 — hit a stock already priced for disappointment.
- The 2025 breach converted a valuation story into a liability story, with the $1B-plus customer compensation program and the $409M regulatory fine adding direct cash costs on top of multiple compression.
Third-order effects
- A $409M penalty tied to inadequate safety controls and negligent management signals that data protection is becoming a recurring, priced-in operating cost for consumer platforms holding tens of millions of accounts.
- If the pattern holds, pandemic-era growth listings face structural re-rating once revenue growth normalizes — with IPO pricing set against peak-cycle comps marking the high-water mark rather than the baseline.
The trend: Post-2021 growth IPOs are being re-rated from revenue multiples to profitability tests, with security failures adding a second layer of repricing risk on top of slowing growth.